Biogen Inc’s recent filing unveils that its Officer Singhal Priya acquired Company’s shares for reported $0.48 million on May 19 ’25. In the deal valued at $126.25 per share,3,806 shares were bought.
Then, DORSA CAROLINE bought 1,235 shares, generating $151,559 in total proceeds. Upon buying the shares at $122.72, the Director now owns 27,842 shares.
Before that, SHERWIN STEPHEN A sold 8,760 shares. Biogen Inc shares valued at $1,314,142 were divested by the Director at a price of $150.02 per share. As a result of the transaction, SHERWIN STEPHEN A now holds 11,318 shares, worth roughly $1.47 million.
HSBC Securities downgraded its Biogen Inc [BIIB] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Argus’s analysts, who decreased its forecast for the stock in early April from “a Buy” to “a Hold”. Bernstein began covering BIIB with “Mkt perform” recommendation on February 11, 2025. Piper Sandler revised its rating on January 02, 2025. It rated BIIB as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of BIIB
On Monday, Biogen Inc [NASDAQ:BIIB] saw its stock jump 3.07% to $129.44. Over the last five days, the stock has gained 4.05%. Biogen Inc shares have fallen nearly -15.35% since the year began. Nevertheless, the stocks have fallen -44.99% over the past one year.
How much short interest is there in Biogen Inc?
A steep rise in short interest was recorded in Biogen Inc stocks on 2025-04-30, dropping by -0.16 million shares to a total of 3.18 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 3.34 million shares. There was a decline of -5.01%, which implies that there is a negative sentiment for the stock.
